Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abuse, acknowledged, adjourned, alert, Amex, argument, arisen, attorney, award, began, blockbuster, certiorari, Charter, cited, climate, commented, compounded, contest, contrary, CRO, damage, damaging, decided, deferral, Department, deployed, desloratadine, Digoxin, diminish, division, DOJ, enjoyed, Ethyol, exacerbate, excellence, export, Farmington, field, formal, FSP, FTC, fuel, fundamental, FY, heavier, hedge, hedging, hierarchy, highest, immaterial, indirectly, insert, Interactive, intervention, Justice, leadership, leverage, LLC, manual, Maryland, MBTA, MedImmune, mg, MI, mind, misleading, misuse, moderate, Modernization, monitoring, nonfinancial, noninfringement, notional, NYSE, Oncology, Orchid, people, percent, platform, poised, post, posted, precautionary, preferential, prejudice, Protonix, prudent, quoted, rapidly, ratably, RBS, regain, reimportation, reiterated, repaglinide, replacing, speculative, stipulated, Supreme, swap, thereunder, today, transparency, trebled, unchanged, unknown, unobservable, untimely, upcoming, USP, viii, voluntarily, Web, willfully, withhold, withholding, writ, Wyeth
Filing tables
Filing exhibits
- 10-K Annual report
- 10.23 Loan Agreement
- 21 Subsidiaries of the Registrant
- 23.01 Consent of Independent Registered Public Accounting Firm.
- 31.1 Certificate of Chief Executive Officer.
- 31.2 Certificate of Chief Financial Officer.
- 32.1 Certification of Chief Executive Officer and Chief Financial Officer Pursuant T
Related press release
CPD similar filings
Filing view
External links
EXHIBIT 23.01
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Caraco Pharmaceutical Laboratories, Ltd.
Detroit, Michigan
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of: the 1993 Stock Option Plan and the 1999 Equity Participation Plan (File No. 333-104429) and the 2008 Equity Participation Plan (File No. 333-158469) of our reports dated May 29, 2009, with respect to the financial statements of Caraco Pharmaceutical Laboratories, Ltd., and the effectiveness of its internal control over financial reporting, included in this Annual Report (Form 10-K) for the year ended March 31, 2009.
|
|
| /s/ Rehmann Robson P.C. |
| |
Troy, Michigan |
|
May 29, 2009 |
|